Global Genomics AB

Global Genomics drives drug discovery. The company develops and out-licenses innovative proprietary tools in functional genomics that provide unique insight into healthy, diseased or drug-treated cells.

In-house expertise in advanced molecular biology techniques and computational analysis has resulted in the company’s first product – tangerine gene expression profiling – a proprietary solution that reveals a whole genome expression profile in a single experiment.

Gene regulation can be studied in any disease or eukaryotic model since there is no prerequisite for initial sequence information. Incorporating tangerine profiling at key stages in drug discovery improves selection of targets and lead compounds, leading to well-validated drug candidates and expediting development of a strong pharmaceuticals portfolio.

Global Genomics AB was founded in September 2000, by Professor Patrik Ernfors and Dr Sten Linnarsson, in co-operation with Karolinska Innovations AB.

Career opportunities

At the moment we don't have any available positions.

If you would like to send us an open application, please send it to:

E-mail: lnyberg@globalgenomics.com

Standard mail:
Global Genomics AB
Attn: Lena Nyberg
Karolinska Science Park
Tomtebodavägen 21B
171 77 Stockholm, Sweden